Startup Funding News
Explore funding rounds, the companies behind them and the investors taking part.
- Rounds
- 749 All time
- Disclosed funding
- $25.4B 612 disclosed amounts
- Median round
- $16M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| F Develops biotech-powered hair supplements using proprietary microencapsulation | Undisclosed | Follow-OnUndisclosed | Healthtech, Biotech | United Kingdom | Investors | |
| S StairMedCompany profile Develops minimally invasive implantable brain-machine interfaces (BMI) for neurological diseases Develops minimally invasive implantable brain-machine interfaces (BMI) for neurological diseases | CN¥500M | StrategicUndisclosed | Healthtech | China | Investors | |
| A Develops real-time nervous system regulation tools | $1.9M | Undisclosed | Healthtech | Finland | Investors | |
| LT Long TailCompany profile Provides AI-native software for utilization management and denials workflows for health systems Provides AI-native software for utilization management and denials workflows for health systems | Undisclosed | Growth | Healthtech | United States | Investors | |
| T TimeSmartAICompany profile Provides AI-driven physician contract compliance and compensation management for healthcare systems Provides AI-driven physician contract compliance and compensation management for healthcare systems | Undisclosed | StrategicUndisclosed | Healthtech | Canada | Investors | |
| AB Ambrosia BiosciencesCompany profile Drug-discovery company developing oral small-molecule treatments for obesity and metabolic disorders. Drug-discovery company developing oral small-molecule treatments for obesity and metabolic disorders. | $100M | Series B | Healthtech, Biotech | United States | Investors | |
| SB Develops implantable lymphatic drainage system to manage lymphedema | $1.5M | Pre-SeedPre-seed | Healthtech | United States | Investors | |
| W Provides wearable health monitoring and personalized health insights | $575M | Series GSeries C+ | Healthtech | United States | Investors 2PointZero GroupAbbott +22AccompliceAffinity PartnersB-FlexionBullhound CapitalCollaborative FundCristiano RonaldoFoundryGlade BrookIVPKaren WazenLeBron JamesMacquarie CapitalMathieu van der PoelMayo ClinicMubadala Investment CompanyNiall HoranPromus VenturesQatar Investment Authority (QIA)Reggie MillerRory McIlroyShane LowryVirgil van Dijk | |
| TB TippingPoint BiosciencesCompany profile Develops novel drug discovery platform to target epigenetic targets in pediatric brain cancer Develops novel drug discovery platform to target epigenetic targets in pediatric brain cancer | $4.5M | Seed | Healthtech, Biotech | United States | Investors | |
| S Develops next-generation cell assay technology for drug discovery | $3.8M | Undisclosed | Healthtech, Biotech | United Kingdom | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · All time
- 1General Catalyst
Baba, Disha (formerly Curelink), Thatch
23rounds2led - 2Y Combinator (YC)
Vitalize, Angle Health, Metriport
21rounds0led - 3Alumni Ventures
MintNeuro, Evvy, Hopscotch Primary Care
13rounds0led - 4Andreessen Horowitz (a16z)
Sharp Performance, General Medicine, Devoted Health
12rounds2led - 5Khosla Ventures
Even Healthcare, Abby Care, Rightway
11rounds1led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.
Browse rounds by topic
Geography
Featured selections
Nordic Foodtech Fund II pairs early capital with scientific expertise
An EIF pledge of up to €30m supports a fund targeting €80m for science-led agrifood companies.
Read the research →